XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Jul. 26, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of reconciliation of the number of options outstanding and exercisable
A reconciliation of the number of options outstanding and exercisable (in thousands) as of July 26, 2020 is:
 
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
Stock Options Outstanding at October 27, 2019
25,994

 
$
26.49

 
 
 
 
Granted
1,218

 
45.88

 
 
 
 
Exercised
5,362

 
15.62

 
 
 
 
Forfeited
185

 
36.35

 
 
 
 
Expired
1

 
36.25

 
 
 
 
Stock Options Outstanding at July 26, 2020
21,664

 
30.18

 
5.4
 
$
435,137

Stock Options Exercisable at July 26, 2020
14,707

 
$
25.85

 
4.1
 
$
359,098
Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised
The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the thirteen and thirty-nine weeks ended July 26, 2020, and July 28, 2019, are:
 
Thirteen Weeks Ended
 
Thirty-Nine Weeks Ended
 
July 26,
2020
 
July 28,
2019
 
July 26,
2020
 
July 28,
2019
Weighted-average Grant Date Fair Value (1)
$
7.22

 
$
—

 
$
7.71

 
$
9.24

Intrinsic Value of Exercised Options
13,254

 
7,308

 
167,148

 
115,094


(1) There were no stock options granted during the thirteen weeks ended July 28, 2019.
Schedule of weighted-average assumptions used to calculate fair value of each option award
The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:
 
Thirteen Weeks Ended
 
Thirty-Nine Weeks Ended
 
July 26,
2020
 
July 28,
2019
 
July 26,
2020
 
July 28,
2019
Risk-free Interest Rate
0.7
%
 
—
%
 
1.7
%
 
2.8
%
Dividend Yield
1.9
%
 
—
%
 
2.0
%
 
1.9
%
Stock Price Volatility
19.0
%
 
—
%
 
19.0
%
 
19.0
%
Expected Option Life
8 years

 
—

 
8 years

 
8 years
Schedule of reconciliation of the nonvested shares
A reconciliation of the restricted stock units (in thousands) as of July 26, 2020 is:
 
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
Restricted Stock Units Outstanding at October 27, 2019
—

 
$
—

 
 
 
 
Granted
205

 
45.88

 
 
 
 
Vested
14

 
45.54

 
 
 
 
Restricted Stock Units Outstanding at July 26, 2020
191

 
$
45.90

 
2.4
 
$
9,599


A reconciliation of the restricted shares (in thousands) as of July 26, 2020 is:
 
Shares
 
Weighted-
Average Grant
Date Fair Value
Restricted Shares Outstanding at October 27, 2019
51

 
$
42.23

Granted
41

 
47.29

Vested
47

 
42.08

Restricted Shares Outstanding at July 26, 2020
45

 
$
47.03
Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted
The weighted-average grant date fair value of restricted shares granted, the total fair value (in thousands) of restricted shares granted, and the fair value (in thousands) of shares that have vested during the thirty-nine weeks ended July 26, 2020, and July 28, 2019, are:
 
Thirty-Nine Weeks Ended
 
July 26,
2020
 
July 28,
2019
Weighted-average Grant Date Fair Value
$
47.29

 
$
42.23

Fair Value of Restricted Shares Granted
1,973

 
2,134

Fair Value of Shares Vested
1,974

 
1,760


The weighted-average grant date fair value of restricted stock units granted and the total fair value (in thousands) of restricted stock units granted during the thirteen and thirty-nine weeks ended July 26, 2020, and July 28, 2019, are:
 
Thirteen Weeks Ended
 
Thirty-Nine Weeks Ended
 
July 26,
2020
 
July 28,
2019
 
July 26,
2020
 
July 28,
2019
Weighted-average Grant Date Fair Value
$
48.76

 
$
—

 
$
45.88

 
$
—

Fair Value of Restricted Stock Units Granted
63

 
—

 
9,383

 
—